Dennis Carson


Dr. Dennis A. Carson, Ph.D., M.D. Co-Founded Wintherix, LLC in 2007 and serves as its Advisor. Dr. Carson serves as an Advisor at Zacharon Pharmaceuticals, Inc., Dr. Carson Co-founded Telormedix SA in 2008 and served as its Advisor. He serves as an Associate Dean for Health Sciences, and Director of Moores Cancer Center at the University of California San Diego Medical Center,La Jolla, California. He served as Clinical Advisor of Syndax Pharmaceuticals, Inc. He founded Vical Inc., Dynavax Technologies Corp., IDEC Pharmaceuticals and Triangle Pharmaceuticals Inc. He served as a Member in the Department of Immunology at The Research Institute of the Scripps Clinic. He has been a Director of Dynavax Technologies Corporation since December 1997. He has been Director of The Rebecca and John Moores UCSD Cancer Center since 2003. He serves as a Member of Scientific Advisory-Board at Telormedix SA and Multimeric Biotherapeutics, Inc. He co-founded Salmedix Inc., and served as its Director since November 2000. He served as a Member of Scientific Advisory Board of Epiphany Biosciences, Inc. He has been Director of the Sam and Rose Stein Institute for Research on Aging since 1990. He is a Member of the American Academy of Arts and Sciences, and the Institute of Medicine, as well as the American Association for Cancer Research, the American Society for Clinical Investigation, the American Society of Hematology, and the Association of American Physicians. He is a Researcher in the fields of autoimmune and immunodeficiency diseases and is Co-discoverer with Dr. Eyal Raz of the immunostimulatory sequences. He holds an adjunct appointment with The Scripps Research Institute. Dr. Carson has been a Professor in the Department of Medicine at the University of California, San Diego since 1995. He joined the UCSD School of Medicine faculty in 1990 as Professor of Medicine. He is a noted Researcher in the field of lymphoproliferative diseases. He developed the drug cladribine. He is also a vaccinologist who originated the concept of "DNA vaccination" using intramuscular injections of DNA encoding vaccine proteins. He was inducted into the National Academy of Sciences in 2003. He has published nearly 450 scientific papers and is an inventor on more than 60 U.S. and international patents. He is an internationally respected Immunologist and Cancer Biologist. He is perhaps best known for his landmark work in developing 2-chlorodeoxyadenosine, or 2-CdA, as Division Head of Immunology Research Foundation. He is awarded by BIOCOM Life Sciences Heritage Award, the Chester Stock Award of Memorial Sloan-Kettering Cancer Center. He received the Arthritis Foundation's highest scientific honor, the Lee C. Howley Sr. Prize for Arthritis Research, an award from the American Association for Cancer Research. He was the 2004 recipient of the AACR-Bruce F. Cain Memorial Award. He received his Medical degree from Columbia University and his B.A. from Haverford College. He did his Internal Medicine training at UCSD. Dr. Carson did his Postgraduate research training at the Salk Institute and the National Institutes of Health and subsequently had an Arthritis Foundation-funded Postdoctoral Fellowship at UCSD.

Source: Bloomberg Businessweek

Interview – March 12, 2006

Interviewed by Ted Everson, PhD

Provided courtesy of the Oral History Program of the Chemical Heritage Foundation.